Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-04

Clinical Trial Update: Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a gemcitabine hydrochloride–cyclophosphamide–vincristine sulfate–prednisolone–rituximab regimen in newly diagnosed diffuse lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytoxan (cyclophosphamide)
  • Gemzar (gemcitabine)
  • Oncovin (vincristine)
  • Orapred (prednisolone)
  • Rituxan (rituximab)

Snippet

Sponsor: University College, London | Conditions: Lymphoma | Phase 2 | Status: COMPLETED